San Jose, CA; September 4, 2025 — In August 2024, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Lykos Therapeutics, declining to approve MDMA-assisted therapy for Posttraumatic Stress Disorder (PTSD). Today, the FDA made this CRL publicly available for the first time, providing transparency into the agency’s decision-making process. … Continue reading MAPS Statement on FDA’s Public Release of Complete Response Letter for MDMA-assisted Therapy| Multidisciplinary Association for Psychedelic Studies – MAPS
August 27, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced today that it has selected Changemark Research + Evaluation (Changemark) as its contract research organization (CRO) for MJP2, a Phase 2 study examining inhaled cannabis for the treatment of Posttraumatic Stress Disorder (PTSD) in Veterans. MJP2 is funded by a $12.9 million grant… Continue reading MAPS Partners with Changemark to Advance Cannabis PTSD Research for Veterans| Multidisciplinary Association for Psychedelic Studies – MAPS
Richard Lee, a pioneering activist who dedicated his life to ending the war on cannabis and to creating opportunities for dignity, education, and freedom, passed away on July 27 in Houston, Texas, from complications of cancer. He was 62. Paralyzed in a workplace accident in 1990, Lee discovered the healing potential of cannabis and transformed… Continue reading Remembering long-time California cannabis activist, Richard Lee| Multidisciplinary Association for Psychedelic Studies – MAPS
WASHINGTON, DC (August 14, 2025) — One year after the FDA’s denial of the New Drug Application for MDMA-assisted therapy for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) has issued an open letter to the U.S. Secretary of Health and Human Services (HHS), Robert F. Kennedy Jr., and Dr. Martin A. Makary, the Commissioner… Continue reading MAPS Urges Action: Open Letter to HHS Secretary and FDA Commissioner One Year After FDA Denial of MDMA-Assisted Therapy for PTSD| Multidisciplinary Association for Psychedelic Studies – MAPS
On Tuesday, the Senate officially confirmed Terrance Cole as the new Administrator of the Drug Enforcement Administration (DEA), marking the first permanent leadership appointment to the agency under President Trump’s second term. Cole’s confirmation comes at a pivotal moment, as the DEA faces mounting pressure to respond to the U.S. Department of Health and Human Services’ recommendation to reschedule cannabis. His leadership will be instrumental in determining how — and whether — ...| Multidisciplinary Association for Psychedelic Studies - MAPS
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos| Multidisciplinary Association for Psychedelic Studies - MAPS
DENVER, June 12, 2025 (GLOBE NEWSWIRE) — With growing recognition of psychedelics and plant medicines in therapeutic and scientific settings, it is a critical time to uplift and acknowledge the Indigenous wisdom and practices that preceded and guide today’s progress. Psychedelic Science 2025 (PS2025) honors these roots with a dedicated Plant Medicine Track that highlights spiritual, cultural,… Continue reading Plant Medicine Track at Psychedelic Science 2025 Spotlights Ancestral Wisdo...| Multidisciplinary Association for Psychedelic Studies – MAPS
• Music Is the Bridge: Frequencies, Visions, Creativity Session at PS2025 Explores the Role of Sound in Emotional Integration, Brainwave Regulation, and Therapeutic Breakthroughs • Reggie Watts, Flying Lotus, Maejor, Jim James, and Vic Mensa Live Performances and Events Bring the Healing Power of Music to Life Beyond the Convention Center DENVER, June 04, 2025… Continue reading Sound, Spirit, and Celebration: Maejor, Jim James, and Vic Mensa Lead the Musical Heartbeat of Psychedelic Sci...| Multidisciplinary Association for Psychedelic Studies – MAPS
DENVER, May 30, 2025 — In the last year, we’ve seen the first-ever FDA review of psychedelic-assisted therapy and state legislatures debating—and passing—bills to create legal access across the country. As momentum for psychedelic policy reform continues to grow, Psychedelic Science 2025 (PS2025) will convene the world’s leading voices to reflect on lessons learned, assess today’s political landscape,… Continue reading Legislators, Advocates, Lawyers, and Organizers Take the ...| Multidisciplinary Association for Psychedelic Studies – MAPS
DENVER, May 29, 2025 — The Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) nonprofit organization at the vanguard of the psychedelic movement since 1986, is bringing its International Therapist Education Program (ITE) to Ukraine. The event is organized in collaboration with the nonprofit Ukrainian Psychedelic Research Association (UPRA) and will take place from April… Continue reading Leaders in Psychiatry, Psychology, and Social Work to Take the Keynote Stage at...| Multidisciplinary Association for Psychedelic Studies – MAPS
Jordan Poyer, Jon Feliciano, and Robert Gallery join Aubrey Marcus to share candid stories of healing, brotherhood, and the work they are doing now.| Multidisciplinary Association for Psychedelic Studies - MAPS
FOR IMMEDIATE RELEASE: September 14, 2023| Multidisciplinary Association for Psychedelic Studies - MAPS
FOR IMMEDIATE RELEASE: December 13, 2023| Multidisciplinary Association for Psychedelic Studies - MAPS
We encourage you to read and follow maps.org/safety for information regarding MAPS Code of Ethics for Psychedelic Psychotherapy and our practices to create a culture of safety in the psychedelic community. | maps.org
Shaping Culture| Multidisciplinary Association for Psychedelic Studies - MAPS
FOR IMMEDIATE RELEASE: August 9, 2024| Multidisciplinary Association for Psychedelic Studies - MAPS